In vitro modulatory effects of ginsenoside compound K, 20(S)-protopanaxadiol and 20(S)-protopanaxatriol on uridine 5′-diphospho-glucuronosyltransferase activity and expression

References

• Bachmann KA, Lewis JD. 2005. Predicting inhibitory drug-drug interactions and evaluating drug interaction reports using inhibition constants. Ann Pharmacother. 39(6):1064–1072.
   PubMed Web of Science ®Google Scholar
• Bang CS, Hong SH, Suk KT, Kim JB, Han SH, Sung H, Kim EJ, Kim MJ, Kim MY, Baik SK, et al. 2014. Effects of Korean red ginseng (Panax ginseng), urushiol (Rhus vernicifera Stokes), and probiotics (Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) on the gut-liver axis of alcoholic liver disease. J Ginseng Res. 38(3):167–172.
   PubMed Web of Science ®Google Scholar
• Caillier B, Lépine J, Tojcic J, Ménard V, Perusse L, Bélanger A, Barbier O, Guillemette C. 2007. A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3. Pharmacogenet Genomics. 17(7):481–495.
   PubMed Web of Science ®Google Scholar
• Chen M-Y, Shao L, Zhang W, Wang C-Z, Zhou H-H, Huang W-H, Yuan C-S. 2018. Metabolic analysis of Panax notoginseng saponins with gut microbiota-mediated biotransformation by HPLC-DAD-Q-TOF-MS/MS. J Pharm Biomed Anal. 150:199–207.
   PubMed Web of Science ®Google Scholar
• Chiu NT, Tomlinson Guns ES, Adomat H, Jia W, Deb S. 2014. Identification of human cytochrome P450 enzymes involved in the hepatic and intestinal biotransformation of 20(S)-protopanaxadiol. Biopharm Drug Dispos. 35(2):104–118.
   PubMed Web of Science ®Google Scholar
• Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK. 2006. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol. 550(1-3):173–179.
   PubMed Web of Science ®Google Scholar
• Choi M-K, Jin S, Jeon J-H, Kang WY, Seong SJ, Yoon Y-R, Han Y-H, Song I-S. 2020. Tolerability and pharmacokinetics of ginsenosides Rb1, Rb2, Rc, Rd, and compound K after single or multiple administration of red ginseng extract in human beings. J Ginseng Res. 44(2):229–237.
   PubMed Web of Science ®Google Scholar
• Fang Z-Z, Cao Y-F, Hu C-M, Hong M, Sun X-Y, Ge G-B, Liu Y, Zhang Y-Y, Yang L, Sun H-Z, et al. 2013. Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs). Toxicol Appl Pharmacol. 267(2):149–154.
   PubMed Web of Science ®Google Scholar
• Feng L, Wang L, Hu C, Jiang X. 2010. Pharmacokinetics, tissue distribution, metabolism, and excretion of ginsenoside Rg1 in rats. Arch Pharm Res. 33(12):1975–1984.
   PubMed Web of Science ®Google Scholar
• He Y-J, Fang Z-Z, Ge G-B, Jiang P, Jin H-Z, Zhang W-D, Yang L. 2013. The inhibitory effect of 20(S)-protopanaxatriol (ppt) towards UGT1A1 and UGT2B7. Phytother Res. 27(4):628–632.
   PubMed Web of Science ®Google Scholar
• He C, Li J, Xu N, Wang R, Li Z, Yang L, Wang Z. 2015. Pharmacokinetics, bioavailability, and metabolism of Notoginsenoside Fc in rats by liquid chromatography/electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal. 109:150–157.
   PubMed Web of Science ®Google Scholar
• Heo SB, Lim SW, Jhun JY, Cho ML, Chung BH, Yang CW. 2016. Immunological benefits by ginseng through reciprocal regulation of Th17 and Treg cells during cyclosporine-induced immunosuppression. J Ginseng Res. 40(1):18–27.
   PubMed Web of Science ®Google Scholar
• Jeong E-S, Kim Y-W, Kim H-J, Shin H-J, Shin J-G, Kim KH, Chi YH, Paik SH, Kim D-H. 2015. Glucuronidation of fimasartan, a new angiotensin receptor antagonist, is mainly mediated by UGT1A3. Xenobiotica. 45(1):10–18.
   PubMed Web of Science ®Google Scholar
• Jin S, Jeon JH, Lee S, et al. 2019. Detection of 13 ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, Compound K, 20(S)-protopanaxadiol, and 20(S)-protopanaxatriol) in human plasma and application of the analytical method to human pharmacokinetic studies following two week-repeated administration of red ginseng extract. Molecules. 24(14):2618. doi: https://doi.org/10.3390/molecules24142618.
   Web of Science ®Google Scholar
• Jin S, Lee S, Jeon JH, Kim H, Choi MK, Song IS. 2019. Enhanced intestinal permeability and plasma concentration of metformin in rats by the repeated administration of red ginseng extract. Pharmaceutics. 11(4):189. doi: https://doi.org/10.3390/pharmaceutics11040189.
   Web of Science ®Google Scholar
• Joo J, Lee B, Lee T, Liu KH. 2014. Screening of six UGT enzyme activities in human liver microsomes using liquid chromatography/triple quadrupole mass spectrometry. Rapid Commun Mass Spectrom. 28(22):2405–2414.
   PubMed Web of Science ®Google Scholar
• Kim S-J, Choi S, Kim M, Park C, Kim G-L, Lee S-O, Kang W, Rhee D-K. 2018. Effect of Korean red ginseng extracts on drug-drug interactions. J Ginseng Res. 42(3):370–378.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim P, Shin CY. 2013. A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system. J Ginseng Res. 37(1):8–29.
   PubMed Web of Science ®Google Scholar
• Kim D, Zheng YF, Min JS, Park JB, Bae SH, Yoon KD, Chin Y-W, Oh E, Bae SK. 2016. In vitro stereoselective inhibition of ginsenosides toward UDP-glucuronosyltransferase (UGT) isoforms. Toxicol Lett. 259:1–10.
   PubMed Web of Science ®Google Scholar
• Kuehl GE, Lampe JW, Potter JD, Bigler J. 2005. Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes. Drug Metab Dispos. 33(7):1027–1035.
   PubMed Web of Science ®Google Scholar
• Lee H, Heo J-K, Lee G-H, Park S-Y, Jang S-N, Kim H-J, Kwon MJ, Song I-S, Liu K-H. 2019. Ginsenoside Rc is a new selective UGT1A9 inhibitor in human liver microsomes and recombinant human UGT isoforms. Drug Metab Dispos. 47(12):1372–1379.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Park JB, Kim D, Bae SH, Chin Y-W, Oh E, Bae SK. 2015. In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions. Toxicol Lett. 232(2):458–465.
   PubMed Web of Science ®Google Scholar
• Li L, Chen X, Li D, Zhong D. 2011. Identification of 20(S)-protopanaxadiol metabolites in human liver microsomes and human hepatocytes. Drug Metab Dispos. 39(3):472–483.
   PubMed Web of Science ®Google Scholar
• Li L, Hu H, Xu S, Zhou Q, Zeng S. 2012. Roles of UDP-glucuronosyltransferases in phytochemical metabolism of herbal medicines and the associated herb-drug interactions. Curr Drug Metab. 13(5):615–623.
   PubMed Web of Science ®Google Scholar
• Ling J, Yu Y, Long J, Li Y, Jiang J, Wang L, Xu C, Duan G. 2019. Tentative identification of 20(S)-protopanaxadiol metabolites in human plasma and urine using ultra-performance liquid chromatography coupled with triple quadrupole time-of-flight mass spectrometry. J Ginseng Res. 43(4):539–549.
   PubMed Web of Science ®Google Scholar
• Liu C, Cao Y-F, Fang Z-Z, Zhang Y-Y, Hu C-M, Sun X-Y, Huang T, Zeng J, Fan X-R, Mo H, et al. 2012. Strong inhibition of deoxyschizandrin and schisantherin A toward UDP-glucuronosyltransferase (UGT) 1A3 indicating UGT inhibition-based herb–drug interaction. Fitoterapia. 83(8):1415–1419.
   PubMed Web of Science ®Google Scholar
• Liu C, Hu M, Guo H, Zhang M, Zhang J, Li F, Zhong Z, Chen Y, Li Y, Xu P, et al. 2015. Combined contribution of increased intestinal permeability and inhibited deglycosylation of ginsenoside Rb1 in the intestinal tract to the enhancement of ginsenoside Rb1 exposure in diabetic rats after oral administration. Drug Metab Dispos. 43(11):1702–1710.
   PubMed Web of Science ®Google Scholar
• Liu D, Wu J, Xie H, Liu M, Takau I, Zhang H, Xiong Y, Xia C. 2016. Inhibitory effect of hesperetin and naringenin on human UDP-glucuronosyltransferase enzymes: implications for herb-drug interactions. Biol Pharm Bull. 39(12):2052–2059.
   PubMed Web of Science ®Google Scholar
• Miners JO, Bowalgaha K, Elliot DJ, Baranczewski P, Knights KM. 2011. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation. Drug Metab Dispos. 39(4):644–652.
   PubMed Web of Science ®Google Scholar
• Nag SA, Qin JJ, Wang W, Wang MH, Wang H, Zhang R. 2012. Ginsenosides as anticancer agents: in vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action. Front Pharmacol. 3:25.
   PubMed Web of Science ®Google Scholar
• Qin Z, Jia M, Yang J, Xing H, Yin Z, Yao Z, Zhang X, Yao X. 2020. Multiple circulating alkaloids and saponins from intravenous Kang-Ai injection inhibit human cytochrome P450 and UDP-glucuronosyltransferase isozymes: potential drug-drug interactions. Chin Med. 15:69.
   PubMed Web of Science ®Google Scholar
• Qu W, Liu X. 2018. Identification of cytochrome P450 isoforms involved in the metabolism of artocarpin and assessment of its drug-drug interaction. Biomed Chromatogr. 32(4). doi: https://doi.org/10.1002/bmc.4149.
   Web of Science ®Google Scholar
• Quan K, Liu Q, Wan J-Y, Zhao Y-J, Guo R-Z, Alolga RN, Li P, Qi L-W. 2015. Rapid preparation of rare ginsenosides by acid transformation and their structure-activity relationships against cancer cells. Sci Rep. 5:8598.
   PubMed Web of Science ®Google Scholar
• Seong SJ, Kang WY, Heo J-K, Jo J, Choi WG, Liu K-H, Lee S, Choi M-K, Han Y-H, Lee HS, et al. 2018. A comprehensive in vivo and in vitro assessment of the drug interaction potential of red ginseng. Clin Ther. 40(8):1322–1337.
   PubMed Web of Science ®Google Scholar
• Soars MG, Petullo DM, Eckstein JA, Kasper SC, Wrighton SA. 2004. An assessment of UDP-glucuronosyltransferase induction using primary human hepatocytes. Drug Metab Dispos. 32(1):140–148.
   PubMed Web of Science ®Google Scholar
• Sun L, Ropartz D, Cui L, Shi H, Ralet MC, Zhou Y. 2019. Structural characterization of rhamnogalacturonan domains from Panax ginseng C. A. Meyer. Carbohydr Polym. 203:119–127.
   PubMed Web of Science ®Google Scholar
• Uchaipichat V, Mackenzie PI, Elliot DJ, Miners JO. 2006. Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases. Drug Metab Dispos. 34(3):449–456.
   PubMed Web of Science ®Google Scholar
• Uchaipichat V, Mackenzie PI, Guo X-H, Gardner-Stephen D, Galetin A, Houston JB, Miners JO. 2004. Human UDP-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab Dispos. 32(4):413–423.
   PubMed Web of Science ®Google Scholar
• Waldrop GL. 2009. A qualitative approach to enzyme inhibition. Biochem Mol Biol Educ. 37(1):11–15.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Z, Wang Z, Chen X, Yin H, Jiang L, Cao J, Liu Y. 2021. Inhibition of human UDP-glucuronosyltransferase enzyme by belinostat: implications for drug-drug interactions. Toxicol Lett. 338:51–57.
   PubMed Web of Science ®Google Scholar
• Xie JT, Mchendale S, Yuan CS. 2005. Ginseng and diabetes. Am J Chin Med. 33(3):397–404.
   PubMed Web of Science ®Google Scholar
• Zhang D, Chando TJ, Everett DW, Patten CJ, Dehal SS, Humphreys WG. 2005. In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation. Drug Metab Dispos. 33(11):1729–1739.
   PubMed Web of Science ®Google Scholar
• Zheng YF, Bae SH, Choi EJ, Park JB, Kim SO, Jang MJ, Park GH, Shin WG, Oh E, Bae SK, et al. 2014. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition. Food Chem Toxicol. 68:117–127.
   PubMed Web of Science ®Google Scholar